BioAtla Inc. (BCAB)
NASDAQ: BCAB
· Real-Time Price · USD
0.48
-0.03 (-5.46%)
At close: Jun 10, 2025, 3:59 PM
BioAtla Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 11M | n/a | n/a | 1.71M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 250K | 150K | 250K | n/a |
Cost of Revenue | n/a | n/a | n/a | 229K | 240K | 368K | 270K | 290K | 293K | 298K | 300K | 288K | 313K | 314K | 380K | 14.85M | 309K |
Gross Profit | n/a | n/a | 11M | -229K | -240K | 1.34M | -270K | -290K | -293K | -298K | -300K | -288K | -313K | -64K | -230K | -14.6M | -309K |
Operating Income | -17.61M | -16.24M | -11.27M | -21.97M | -24.46M | -28.54M | -35.02M | -37.2M | -28.93M | -28.56M | -26.18M | -29.05M | -24.35M | -23.49M | -23.7M | -30.46M | -18.8M |
Interest Income | 400K | 554K | 692K | 900K | 1.22M | 1.64M | 1.73M | 1.46M | 1.48M | 1.05M | 370K | 146K | 85K | 96K | 76K | 80K | 98K |
Pretax Income | -15.33M | -14.88M | -10.59M | -21.07M | -23.23M | -26.93M | -33.33M | -35.75M | -27.46M | -27.54M | -25.78M | -28.91M | -24.25M | -23.39M | -22.93M | -30.38M | -18.7M |
Net Income | -15.33M | -14.88M | -10.59M | -21.07M | -23.23M | -26.93M | -33.33M | -35.75M | -25.99M | -27.76M | -25.41M | -28.76M | -24.16M | -23.39M | -22.93M | -30.38M | -18.7M |
Selling & General & Admin | 5.26M | 4.59M | 5.88M | 5.54M | 5.37M | 5.49M | 6.62M | 6.24M | 7.23M | 6.69M | 6.34M | 8.34M | 7.42M | 7.04M | 7.14M | 15.86M | 8.37M |
Research & Development | 12.36M | 11.65M | 16.39M | 16.2M | 18.85M | 22.67M | 28.4M | 30.96M | 21.7M | 21.87M | 19.84M | 20.71M | 16.92M | 16.45M | 16.55M | 14.85M | 10.42M |
Other Expenses | n/a | n/a | n/a | 229K | n/a | -27K | -39K | -11K | -10K | -30K | 30K | 3K | 7K | 2K | -1K | n/a | n/a |
Operating Expenses | 17.61M | 16.24M | 22.27M | 21.74M | 24.22M | 28.17M | 35.02M | 37.2M | 28.93M | 28.56M | 26.18M | 29.05M | 24.35M | 23.49M | 23.7M | 30.71M | 18.8M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 1.47M | n/a | n/a | n/a | n/a | 370K | 146K | n/a | n/a | 76K | 1K | 2K |
Selling & Marketing Expenses | n/a | n/a | n/a | -229K | -240K | -368K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 17.61M | 16.24M | 22.27M | 21.97M | 24.46M | 28.54M | 35.02M | 37.2M | 28.93M | 28.56M | 26.18M | 29.05M | 24.35M | 23.49M | 23.7M | 30.71M | 18.8M |
Income Tax Expense | n/a | n/a | n/a | n/a | 196.72K | 4.93M | -2M | -1.46M | -1.47M | 218K | -370K | -146K | -92K | 2K | -1K | 80K | 98K |
Shares Outstanding (Basic) | 58.25M | 49.95M | 48.34M | 48.21M | 48.09M | 48.03M | 47.83M | 47.71M | 47.58M | 44.01M | 37.52M | 37.42M | 37.32M | 33.68M | 33.91M | 33.68M | 33.63M |
Shares Outstanding (Diluted) | 58.25M | 49.95M | 48.34M | 48.21M | 48.09M | 48.03M | 47.83M | 47.71M | 47.58M | 44.01M | 37.52M | 37.42M | 37.32M | 33.68M | 33.91M | 33.68M | 33.63M |
EPS (Basic) | -0.26 | -0.31 | -0.22 | -0.44 | -0.48 | -0.56 | -0.7 | -0.75 | -0.55 | -0.63 | -0.68 | -0.77 | -0.65 | -0.69 | -0.68 | -0.9 | -0.56 |
EPS (Diluted) | -0.26 | -0.31 | -0.22 | -0.44 | -0.48 | -0.56 | -0.7 | -0.75 | -0.55 | -0.63 | -0.68 | -0.77 | -0.65 | -0.69 | -0.68 | -0.9 | -0.56 |
EBITDA | -17.43M | -16.02M | -11.04M | -21.97M | -24.22M | -28.17M | -34.75M | -36.91M | -28.64M | -27.25M | -25.88M | -28.77M | -24.03M | -23.08M | -22.55M | -30.05M | -18.39M |
EBIT | -17.61M | -14.88M | -11.27M | -21.97M | -24.46M | -28.54M | -35.02M | -37.2M | -28.93M | -27.54M | -26.18M | -29.05M | -24.35M | -23.39M | -22.93M | -30.38M | -18.7M |
Depreciation & Amortization | 183K | 228K | 228K | 229K | 240K | 368K | 270K | 290K | 293K | 298K | 300K | 288K | 313K | 314K | 380K | 327K | 309K |